https://www.biospace.com/eyepoint-pharmaceuticals-to-host-r-and-d-day-on-june-26-2024
EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024 - BioSpace
eyepoint pharmaceuticalsto hostd day
https://www.benzinga.com/insights/analyst-ratings/24/10/41546223/analyst-ratings-for-eyepoint-pharmaceuticals
Analyst Ratings For EyePoint Pharmaceuticals - EyePoint (NASDAQ:EYPT) - Benzinga
analyst ratingseyepoint pharmaceuticalsnasdaqeyptbenzinga
https://www.biospace.com/eyepoint-pharmaceuticals-reports-positive-results-from-glp-toxicology-study-of-eyp-1901-a-potential-six-month-treatment-of-wet-age-related-macular-degeneration
EyePoint Pharmaceuticals Reports Positive Results from GLP Toxicology Study of EYP-1901, a...
Dec 3, 2020 - EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today...
https://www.biospace.com/press-releases/eyepoint-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-march-17-2025
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - March 17,...